Maria A. Sala

Bilbao, PV, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

ARIAN protocol: a phase III study of sacituzumab and zimberelimab for the treatment of patients with non-small cell lung cancer.

ARIAN protocol: a phase III study of sacituzumab and zimberelimab for the treatment of patients with non-small cell lung cancer.

Journal: Expert opinion on biological therapy

Published: May 20, 2026

Observational study on the safety and effectiveness of SARS-CoV-2 vaccination in patients with lung cancer.

Observational study on the safety and effectiveness of SARS-CoV-2 vaccination in patients with lung cancer.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial.

Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial.

Journal: Nature communications

Published: May 23, 2025

AI WAVEMAR: Design of an artificial intelligence model for detecting suspicious findings in screening mammography.

AI WAVEMAR: Design of an artificial intelligence model for detecting suspicious findings in screening mammography.

Journal: Radiologia

Published: April 24, 2025

Incidence of second primary cancers in lung cancer survivors by oncological treatment: a nationwide prospective cohort study in Spain.

Incidence of second primary cancers in lung cancer survivors by oncological treatment: a nationwide prospective cohort study in Spain.

Journal: The Lancet regional health. Europe

Published: April 10, 2025

Efficacy and safety of bintrafusp alfa evaluated in a phase II single-arm clinical trial in previously treated advanced pleural mesothelioma.

Efficacy and safety of bintrafusp alfa evaluated in a phase II single-arm clinical trial in previously treated advanced pleural mesothelioma.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 27, 2025

Comprehensive molecular profiling of advanced NSCLC using NGS: Prevalence of druggable mutations and clinical trial opportunities in the ATLAS study.

Comprehensive molecular profiling of advanced NSCLC using NGS: Prevalence of druggable mutations and clinical trial opportunities in the ATLAS study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 19, 2025

SEOM-GEIS Spanish clinical guidelines for the management of soft‑tissue sarcomas (2024).

SEOM-GEIS Spanish clinical guidelines for the management of soft‑tissue sarcomas (2024).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 20, 2024

Lurbinectedin is an effective alternative to platinum rechallenge and may restore platinum sensitivity in patients with sensitive relapsed small cell lung cancer.

Lurbinectedin is an effective alternative to platinum rechallenge and may restore platinum sensitivity in patients with sensitive relapsed small cell lung cancer.

Journal: Expert review of anticancer therapy

Published: December 11, 2024

KRAS Mutation Status in Non-Small Cell Lung Cancer Distribution Across Occupational Categories.

KRAS Mutation Status in Non-Small Cell Lung Cancer Distribution Across Occupational Categories.

Journal: Chest

Published: December 05, 2024

Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor.

Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 02, 2024

ctDNA Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or without Bevacizumab from the Randomized Phase II ETOP-BOOSTER Trial.

ctDNA Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or without Bevacizumab from the Randomized Phase II ETOP-BOOSTER Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 28, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026